137 related articles for article (PubMed ID: 36989848)
1. Prognostic impact of CD73/adenosine 2A receptor (A2AR) in renal cell carcinoma and immune microenvironmental status with sarcomatoid changes and rhabdoid features.
Takamatsu D; Kiyozawa D; Kohashi K; Kinoshita F; Toda Y; Ishihara S; Eto M; Oda Y
Pathol Res Pract; 2023 Apr; 244():154423. PubMed ID: 36989848
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival.
Kamai T; Kijima T; Tsuzuki T; Nukui A; Abe H; Arai K; Yoshida KI
Cancer Immunol Immunother; 2021 Jul; 70(7):2009-2021. PubMed ID: 33416945
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
Tripathi A; Lin E; Xie W; Flaifel A; Steinharter JA; Stern Gatof EN; Bouchard G; Fleischer JH; Martinez-Chanza N; Gray C; Mantia C; Thompson L; Wei XX; Giannakis M; McGregor BA; Choueiri TK; Agarwal N; McDermott DF; Signoretti S; Harshman LC
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33177176
[TBL] [Abstract][Full Text] [Related]
4. Programmed death ligand 1/indoleamine 2,3-dioxygenase 1 expression and tumor-infiltrating lymphocyte status in renal cell carcinoma with sarcomatoid changes and rhabdoid features.
Kiyozawa D; Takamatsu D; Kohashi K; Kinoshita F; Ishihara S; Toda Y; Eto M; Oda Y
Hum Pathol; 2020 Jul; 101():31-39. PubMed ID: 32360490
[TBL] [Abstract][Full Text] [Related]
5. Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL.
Zhang T; Liu H; Jiao L; Zhang Z; He J; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Zhang H; Wang X
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365585
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
[TBL] [Abstract][Full Text] [Related]
7. Adenosine Generated by Regulatory T Cells Induces CD8
Shi L; Feng M; Du S; Wei X; Song H; Yixin X; Song J; Wenxian G
Biomed Res Int; 2019; 2019():4093214. PubMed ID: 31930120
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Role of CD73/A2AR Expression and Tumor Immune Response in Periampullary Carcinoma Subtypes.
Sweed D; Taha M; Abd Elhamed S; El Dein Mohamed AS
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1239-1246. PubMed ID: 35485681
[TBL] [Abstract][Full Text] [Related]
9. Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome.
Wang X; Zhang T; Song Z; Li L; Zhang X; Liu J; Liu X; Qiu L; Qian Z; Zhou S; Feng L; Hu G; Meng B; Zhai Q; Ren X; Fu K; Li L; Wang P; Zhang H
Int J Cancer; 2019 Sep; 145(5):1414-1422. PubMed ID: 30664812
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
[TBL] [Abstract][Full Text] [Related]
11. Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.
Fong L; Hotson A; Powderly JD; Sznol M; Heist RS; Choueiri TK; George S; Hughes BGM; Hellmann MD; Shepard DR; Rini BI; Kummar S; Weise AM; Riese MJ; Markman B; Emens LA; Mahadevan D; Luke JJ; Laport G; Brody JD; Hernandez-Aya L; Bonomi P; Goldman JW; Berim L; Renouf DJ; Goodwin RA; Munneke B; Ho PY; Hsieh J; McCaffery I; Kwei L; Willingham SB; Miller RA
Cancer Discov; 2020 Jan; 10(1):40-53. PubMed ID: 31732494
[TBL] [Abstract][Full Text] [Related]
12. CD39/CD73/A2AR pathway and cancer immunotherapy.
Xia C; Yin S; To KKW; Fu L
Mol Cancer; 2023 Mar; 22(1):44. PubMed ID: 36859386
[TBL] [Abstract][Full Text] [Related]
13. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy.
Kurago Z; Guo G; Shi H; Bollag RJ; Groves MW; Byrd JK; Cui Y
Front Immunol; 2023; 14():1212209. PubMed ID: 37435071
[TBL] [Abstract][Full Text] [Related]
15. [Renal cell carcinoma with sarcomatoid and rhabdoid features: a clinico-pathological series of 74 cases].
Queipo FJ; Panizo A; Sola JJ; Beorlegui C; Velis JM; Dolezal P; Pardo-Mindán J
An Sist Sanit Navar; 2018 Aug; 41(2):191-199. PubMed ID: 30063035
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
[TBL] [Abstract][Full Text] [Related]
17. A2AR Expression and Immunosuppressive Environment Independent of
Kusamura S; Busico A; Conca E; Capone I; Agnelli L; Lorenzini D; Brich S; Angelini M; Volpi CC; Trupia DV; Lagano V; Torelli T; Gloghini A; Baratti D; Guaglio M; Milione M; Deraco M; Perrone F
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509688
[TBL] [Abstract][Full Text] [Related]
18. The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinoma.
Hahn AW; Lebenthal J; Genovese G; Sircar K; Tannir NM; Msaouel P
Cancer Treat Res Commun; 2022; 33():100640. PubMed ID: 36174377
[TBL] [Abstract][Full Text] [Related]
19. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
20. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
Delahunt B; Cheville JC; Martignoni G; Humphrey PA; Magi-Galluzzi C; McKenney J; Egevad L; Algaba F; Moch H; Grignon DJ; Montironi R; Srigley JR;
Am J Surg Pathol; 2013 Oct; 37(10):1490-504. PubMed ID: 24025520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
